evaluated 117 patients with T-ALL and found that the genetic signature of ETP-ALL was best correlated with the following immunophenotype: CD1a-negative, CD4 and CD8-double negative, CD34-positive, and/or CD13/CD33-positive. The gene discussed is CD1A; the disease is acute lymphoblastic leukemia.